Inspire Medical (INSP) director gets 342-share stock fee grant

Rhea-AI Filing Summary

Broader Shelley G reported acquisition or exercise transactions in this Form 4 filing.

Inspire Medical Systems director Shelley G. Broader received 342 shares of Common Stock as a stock grant. The shares were valued at $52.07 per share and were issued in lieu of cash fees under the company’s Non-Employee Director Compensation Policy. Following this routine compensation award, Broader directly holds a total of 4,909 shares of Inspire Medical Systems Common Stock.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Broader Shelley G

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	342	$52.07	$18K

Holdings After Transaction: Common Stock — 4,909 shares (Direct)

Footnotes (1)

1. [object Object]

Key Figures

Stock grant size: 342 shares Grant valuation price: $52.07 per share Post-transaction holdings: 4,909 shares

3 metrics

Stock grant size 342 shares Common Stock awarded to Shelley G. Broader

Grant valuation price $52.07 per share Value used for the 342-share award

Post-transaction holdings 4,909 shares Direct Common Stock owned by Shelley G. Broader after grant

Key Terms

Non-Employee Director Compensation Policy, Common Stock, grant/award acquisition

3 terms

Non-Employee Director Compensation Policy financial

"pursuant to the Company's Non-Employee Director Compensation Policy"

Common Stock financial

"Represents shares of common stock received in lieu of cash fees"

Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.

grant/award acquisition financial

"transaction_action: grant/award acquisition"

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Broader Shelley G

(Last) (First) (Middle)

C/O INSPIRE MEDICAL SYSTEMS, INC.

5500 WAYZATA BLVD., SUITE 1600

(Street)

GOLDEN VALLEY MINNESOTA 55416

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Inspire Medical Systems, Inc. [ INSP ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
04/15/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	04/15/2026		A		342(1)	A	$52.07	4,909	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents shares of common stock received in lieu of cash fees pursuant to the Company's Non-Employee Director Compensation Policy.

	/s/ Bryan Phillips, Attorney-in-Fact for Shelley G. Broader	04/16/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did Inspire Medical Systems (INSP) director Shelley G. Broader report?

Shelley G. Broader reported receiving 342 shares of Inspire Medical Systems Common Stock. The shares were granted as part of director compensation rather than bought on the market, reflecting routine equity-based pay instead of an open-market purchase or sale.

At what price were the Inspire Medical Systems (INSP) shares granted to Shelley G. Broader?

The grant to Shelley G. Broader was valued at $52.07 per share. This value is used for reporting the compensation cost of the stock award and does not represent an open-market trade price chosen by the director.

How many Inspire Medical Systems (INSP) shares does Shelley G. Broader hold after this grant?

After receiving the 342-share grant, Shelley G. Broader directly holds 4,909 Inspire Medical Systems Common Stock shares. This figure reflects her updated direct ownership position following the non-employee director compensation award.

Was the Inspire Medical Systems (INSP) share grant to Shelley G. Broader an open-market purchase?

No, the 342 shares were not an open-market purchase. They were issued in lieu of cash fees under Inspire Medical Systems’ Non-Employee Director Compensation Policy, making this a routine equity compensation grant rather than a discretionary market transaction.

Why did Shelley G. Broader receive Inspire Medical Systems (INSP) shares instead of cash?

Shelley G. Broader received the 342 shares in lieu of cash fees pursuant to Inspire Medical Systems’ Non-Employee Director Compensation Policy. This policy allows non-employee directors to be compensated partly with stock, aligning board compensation with company equity.